Rectal indomethacin should be used routinely in all patients for prevention of post-ERCP pancreatitis

JA Barkin, EO Souto, JS Barkin - Gastrointestinal endoscopy, 2017 - giejournal.org
We read with great interest the recent meta-analysis by Inamdar et al 1 on the utility of rectal
indomethacin in the prevention of post-ERCP pancreatitis (PEP). According to their strict …

Does rectal indomethacin prevent post-ERCP pancreatitis in average-risk patients?

X He, L Sun - Gastrointestinal Endoscopy, 2017 - giejournal.org
We read with great interest the recent meta-analysis by Inamdar et al 1 on the utility of rectal
indomethacin in the prevention of post-ERCP pancreatitis (PEP). According to their strict …

Lowering the risk of post-ERCP pancreatitis

NR Thiruvengadam, KA Forde… - Gastrointestinal …, 2017 - giejournal.org
Gastrointestinal Endoscopy by Inamdar et al. 1 They demonstrated that indomethacin
reduced PEP in high-risk patients. However, they concluded that among averagerisk …

720 A Randomized Controlled Trial of Rectal Indomethacin for the Prevention of Post-ERCP Pancreatitis

BJ Elmunzer, JM Scheiman, GA Lehman… - Gastrointestinal …, 2012 - giejournal.org
Background Pancreatitis is the most frequent complication of endoscopic retrograde
cholangiopancreatography (ERCP), accounting for substantial morbidity, occasional …

[引用][C] 541 a randomized trial of rectal indomethacin and papillary spray of epinephrine versus rectal indomethacin alone for the prevention of post-ercp pancreatitis in …

A Kamal, VS Akshintala, R Talukdar… - Gastrointestinal …, 2017 - giejournal.org
Background Rectal indomethacin and papillary spray of epinephrine have been separately
shown to be efficacious for the prevention of post-ERCP pancreatitis (PEP) in randomized …

[PDF][PDF] Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials

N Shi, L Deng, K Altaf, W Huang, P Xue… - Turk J …, 2015 - turkjgastroenterol.org
ABSTRACT Background/Aims: This meta-analysis was undertaken to evaluate the effect of
rectal indomethacin in the prevention of post-endoscopic retrograde …

Rectal indomethacin for post-ERCP pancreatitis prophylaxis in average risk patients: too early to terminate and too early to conclude

VS Akshintala, VK Singh, DN Reddy - Gastroenterology, 2016 - gastrojournal.org
Dear Editors: We read with great interest the study by Levenick et al entitled,“Rectal
Indomethacin Does not Prevent Post-ERCP Pancreatitis in Consecutive Patients.” 1 The …

Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis

S Inamdar, D Han, M Passi, DV Sejpal… - Gastrointestinal …, 2017 - Elsevier
Background and Aims Rectal indomethacin is a popular chemopreventive agent to help
prevent post-ERCP pancreatitis (PEP). Previous meta-analyses have shown an overall …

Rectal indomethacin to prevent post-ERCP pancreatitis

A Akhter, PR Pfau, DV Gopal - Gastroenterology, 2016 - gastrojournal.org
568 Correspondence Gastroenterology Vol. 151, No. 3 in this study was approximately 64
years of age and thus, may also predispose the study population to a lower risk of PEP when …

Effect of rectal indomethacin for preventing post-ERCP pancreatitis depends on difficulties of cannulation: results from a randomized study with sequential biliary …

Á Patai, N Solymosi, ÁV Patai - Journal of clinical gastroenterology, 2015 - journals.lww.com
Results: In 70.3% of patients, biliary intubation was successful in the first 5 atraumatic
attempts, PEP rate was low, and indomethacin was ineffective (7.4% in the placebo group …